A randomized phase II trial of sequential gemcitabine plus vinorelbine followed by gemcitabine plus Ifosfamide versus gemcitabine plus cisplatin in the treatment of chemonaive patients with stage III and IV non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Teodorescu, G
Ciuleanu, T
Grigorescu, A
Firoiu, E
Muresan, DR
机构：
[1] Eli Lilly SRL, Bucharest, Romania
[2] Cluj Oncol Inst, Cluj Napoca, Romania
[3] Bucharest Oncol Inst, Bucharest, Romania
[4] Targoviste Cty Hosp, Targoviste, Romania
[5] Oradea Cty Hosp, Oradea, Romania
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
10.1016/S0169-5002(05)81075-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S271 / S272
页数：2
相关论文
共 50 条
  • [21] Phase I II study of CDDP plus vinorelbine plus gemcitabine in non-small cell lung carcinoma (NSCLC).
    Esteban, E
    Fra, J
    Puertas, J
    Sala, MA
    Carrasco, J
    Palacio, I
    Muñiz, I
    Vieitez
    Lacave, AJ
    Buesa, JM
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S62 - S62
  • [22] Gemcitabine plus cisplatin in advanced non-small cell lung cancer (NSCLC): A phase II study
    Orlandi-Jorquera, L
    Orlandi, F
    Galaz, P
    Gamargo, C
    Salman, P
    Yanez, M
    ANNALS OF ONCOLOGY, 1998, 9 : 101 - 101
  • [23] Randomized phase II study of induction chemotherapy with gemcitabine plus cisplatin followed by sequential radiotherapy versus radiotherapy alone in patients with Stage III non-small cell lung cancer
    Beslija, Semir
    Jesenko, Lomigoric
    Adnan, Cardzic
    Nermina, Obralic
    ANNALS OF ONCOLOGY, 2004, 15 : 173 - 173
  • [24] Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer
    Stemmler, H. J.
    diGioia, D.
    Freier, W.
    Tessen, H. W.
    Gitsch, G.
    Jonat, W.
    Brugger, W.
    Kettner, E.
    Abenhardt, W.
    Tesch, H.
    Hurtz, H. J.
    Roesel, S.
    Brudler, O.
    Heinemann, V.
    BRITISH JOURNAL OF CANCER, 2011, 104 (07) : 1071 - 1078
  • [25] Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer
    H J Stemmler
    D diGioia
    W Freier
    H W Tessen
    G Gitsch
    W Jonat
    W Brugger
    E Kettner
    W Abenhardt
    H Tesch
    H J Hurtz
    S Rösel
    O Brudler
    V Heinemann
    British Journal of Cancer, 2011, 104 : 1071 - 1078
  • [26] Gemcitabine (GEM) plus vinorelbine (NVB) in non-small cell lung cancer (NSCLC)
    Michetti, G
    Beretta, GD
    Belometti, MO
    Gritti, G
    Marini, B
    Agazzi, A
    Labianca, R
    ANNALS OF ONCOLOGY, 1998, 9 : 91 - 92
  • [27] Gemcitabine plus vinorelbine (GEMVIN) in the treatment of advanced non-small cell lung cancer (NSCLC). Sequential phase I and phase II trials
    Cigolari, S
    Gridelli, C
    Frontini, L
    Gulisano, M
    Robbiati, SF
    Farris, A
    Clerici, M
    Castiglione, F
    Piazza, E
    Ianniello, GP
    Perrone, F
    ANNALS OF ONCOLOGY, 1998, 9 : 87 - 87
  • [28] Gemcitabine plus vinorelbine for the treatment of advanced non-small cell lung cancer
    Barón, F
    Cueva, J
    Graña, B
    Curiel, T
    León, L
    Vázquez, F
    Candamio, S
    López, R
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (11) : 1381 - 1384
  • [29] Gemcitabine plus cisplatin in non-small cell lung cancer: A Phase II study
    Sandler, A
    Ansari, R
    McClean, J
    Fisher, W
    Dorr, FA
    Einhorn, LH
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1079 - 1079
  • [30] Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma: A randomized phase II trial
    Hsu, C.
    Cheng, A.
    Shih, J.
    Yu, C.
    Kuo, S.
    Lin, C.
    Huang, T.
    Yang, P.
    Yang, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345